For research use only. Not for therapeutic Use.
Veralipride is a benzamide neuroleptic medicine indicated in the treatment of vasomotor symptoms associated with the menopause. It was first authorised for use in 1979. Veralipride was withdraw from the market in 2007.
| Catalog Number | R013419 |
| CAS Number | 66644-81-3 |
| Synonyms | 5-(Aminosulfonyl)-2,3-dimethoxy-N-[[1-(2-propen-1-yl)-2-pyrrolidinyl]methyl]benzamide; (+/-)-Veralipride; Agreal; LIR 1660; |
| Molecular Formula | C₁₇H₂₅N₃O₅S |
| Purity | ≥95% |
| Target | Neuronal Signaling |
| Storage | -20°C |
| Reference | </br>1:Safety of veralipride for the treatment of vasomotor symptoms of menopause. Valencia MH, Arias Mde J, González CC, Marín IH, González JH, Campos ER, Rodríguez MA, Álvarez IM, Vargas MA, Flores JB, Haro SS, Bonilla MC, Escudero RB, Campero RA.Menopause. 2014 May;21(5):484-92. doi: 10.1097/GME.0b013e3182a46dcb. PMID: 24065139 </br>2:[Consensus conference of the Mexican Association for the Study of Climateric on veralipride prescription for patients with vasomotor symptoms]. Basavilvazo-Rodríguez A, Bravo-Rodríguez LM, Carranza-Lira S, Celis-González C, Hernández Marín I, Hernández-Valencia M, López Navarro ME, Alvarado Maldonado Jde D, Armando Montaño J, Moreno Avellán AJ, Vázquez G.Ginecol Obstet Mex. 2012 Jul;80(7):467-72. Spanish. PMID: 22916640 </br>3:[Parkinsonism induced by sulpiride and veralipride: two different stories]. Martí Massó JF, Ruiz-Martínez J, Bergareche A, López de Munain A.Med Clin (Barc). 2011 Oct 15;137(10):473-4. doi: 10.1016/j.medcli.2010.09.038. Epub 2011 Feb 4. Spanish. No abstract available. PMID: 21295788 </br>4:Actual status of veralipride use. Carranza-Lira S.Clin Interv Aging. 2010 Sep 7;5:271-6. Review. PMID: 20852674 Free PMC Article</br>5:Reduction of serum serotonin precursors after veralipride treatment for postmenopausal hot flushes. Carretti N, Florio P, Reis FM, Comai S, Bertazzo A, Petraglia F.Climacteric. 2010 Apr;13(2):141-6. doi: 10.3109/13697130903219208. PMID: 20082603 </br>6:Tardive blepharospasm beginning after withdrawal of veralipride. Alonso-Navarro H, Jiménez-Jiménez FJ.Mov Disord. 2006 Nov;21(11):2033-4. No abstract available. PMID: 16960858 </br>7:Veralipride-induced acute coronary syndrome unmasking a non-secreting pheochromocytoma. Montemurro D, Rossi GP.J Endocrinol Invest. 2006 Jul-Aug;29(7):650-2. PMID: 16957415 </br>8:The safety of veralipride. De Leo V, Morgante G, Musacchio MC, Faldini E, Delia A, Petraglia F.Expert Opin Drug Saf. 2006 Sep;5(5):695-701. Review. PMID: 16907659 </br>9:Tardive dyskinesia after long-term veralipride treatment. Raja M, Azzoni A.J Neuropsychiatry Clin Neurosci. 2005 Spring;17(2):252-3. No abstract available. PMID: 15939983 </br>10:[Extrapyramidal adverse effects of veralipride (Agreal), a drug used to treat hot flushes: a propos of 17 cases]. Masmoudi K, Gras-Champel V, Lemaire-Hurtel AS, Masson H, Munier A, Geslin JM, Andréjak M.Rev Med Interne. 2005 Jun;26(6):453-7. Epub 2005 Mar 17. French. PMID: 15936474 |
